Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | KTX-2001 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on KTX-2001, a putative NSD2 inhibitor (Aug 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| KTX-2001 | KTX2001|KTX 2001 | Limited information is currently available on KTX-2001, a putative NSD2 inhibitor (Aug 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07103018 | Phase I | KTX-2001 Darolutamide + KTX-2001 | A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001) (STRIKE-001) | Recruiting | USA | 0 |